These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9743383)

  • 1. Signaling through a CD3 gamma-deficient TCR/CD3 complex in immortalized mature CD4+ and CD8+ T lymphocytes.
    Pacheco-Castro A; Alvarez-Zapata D; Serrano-Torres P; Regueiro JR
    J Immunol; 1998 Sep; 161(6):3152-60. PubMed ID: 9743383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells.
    Davidson WF; Calkins C; Hügins A; Giese T; Holmes KL
    J Immunol; 1991 Jun; 146(12):4138-48. PubMed ID: 1674953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte signalling defects and immunodeficiency due to the lack of CD3 gamma.
    Arnaiz-Villena A; Timon M; Rodriguez-Gallego C; Iglesias-Casarrubios P; Pacheco A; Regueiro JR
    Immunodeficiency; 1993; 4(1-4):121-9. PubMed ID: 7909475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
    Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
    J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpesvirus saimiri-transformed human CD4+ T cells can provide polyclonal B cell help via the CD40 ligand as well as the TNF-alpha pathway and through release of lymphokines.
    Saha K; Ware R; Yellin MJ; Chess L; Lowy I
    J Immunol; 1996 Nov; 157(9):3876-85. PubMed ID: 8892618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity.
    Nakajima H; Leonard WJ
    J Immunol; 1999 Jan; 162(2):782-90. PubMed ID: 9916699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-deficient transmembrane signaling in CD4+ T cells of retroviral-induced immune-deficient mice.
    Fitzpatrick EA; Bryson JS; Rhoads C; Kaplan AM; Cohen DA
    J Immunol; 1992 Jun; 148(11):3377-84. PubMed ID: 1350288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.
    De Lau WB; Boom SE; Heije K; Griffioen AW; Braakman E; Bolhuis RL; Tax WJ; Clevers H; Bast BJ
    J Immunol; 1992 Sep; 149(6):1840-6. PubMed ID: 1387662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
    Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
    J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
    Budd RC; Winslow G; Inokuchi S; Imboden JB
    J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deficiency of the CD3-TCR signal pathway in three patients with idiopathic CD4+ lymphocytopenia].
    Hubert P; Bergeron F; Grenot P; Seligman M; Krivitzky A; Debré P; Autran B
    J Soc Biol; 1999; 193(1):11-6. PubMed ID: 10851550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor alpha-chain tail is required for protein kinase C-mediated down-regulation, but not for signaling.
    Bäckström BT; Rubin B; Peter A; Tiefenthaler G; Palmer E
    Eur J Immunol; 1997 Jun; 27(6):1433-41. PubMed ID: 9209496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.